Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
40.80
+6.95 (20.53%)
Apr 20, 2026, 1:24 PM CST
143.58% (1Y)
| Market Cap | 1.54B +83.9% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 45.37M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 624,604 |
| Open | 34.30 |
| Previous Close | 33.85 |
| Day's Range | 34.20 - 41.20 |
| 52-Week Range | 15.70 - 41.15 |
| Beta | -0.35 |
| RSI | 84.50 |
| Earnings Date | n/a |